Acute bacterial skin and skin structure infection (ABSSSI) Erysipelas research hub

Pilot Study - Safety and Efficacy of Dalbavancin in Early Outpatient Treatment of Erysipelas and Limited Cellulitis

This study looks at a medicine called Dalbavancin (Xydalba) for skin infections like erysipelas. It checks how well it works and if it's safe for people to go home quickly after treatment. The study mainly focuses on how soon patients can leave the hospital.